Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model-Reference-Cited by-同舟云学术

Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model

Published:2015 Issue: Volume:4 Page:e258
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Takanashi Masakatsu,Sudo Katsuko,Ueda Shinobu,Ohno Shin-Ichiro,Yamada Yuko,Osakabe Yasuhiro,Goto Hiroshi,Matsunaga Yoshimichi,Ishikawa Akio,Usui Yoshihiko,Kuroda Masahiko

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference41 articles.

1. Choice of cell source in cell-based therapies for retinal damage due to age-related macular degeneration: a review;John;J Ophthalmol,2013

2. Downregulation of p22phox in retinal pigment epithelial cells inhibits choroidal neovascularization in mice;Li;Mol Ther,2008

3. The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy;Carter;Angiogenesis,2015

4. Targeting vascular endothelial growth factor: a promising strategy for treating age-related macular degeneration;Waisbourd;Drugs Aging,2007

5. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3;Alexopoulou;Nature,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes;Molecular Therapy - Nucleic Acids;2024-09

2. Periostin in Eye Diseases;Advances in Experimental Medicine and Biology;2019

3. Periostin in vitreoretinal diseases;Cellular and Molecular Life Sciences;2017-09-14

4. Therapeutic potentials of short interfering RNAs;Applied Microbiology and Biotechnology;2017-08-08

5. A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides;International Journal of Pharmaceutics;2017-08